A detailed history of Holderness Investments CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Holderness Investments CO holds 2,301 shares of LLY stock, worth $1.83 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
2,301
Previous 2,261 1.77%
Holding current value
$1.83 Million
Previous $2.05 Million 0.44%
% of portfolio
0.45%
Previous 0.49%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $30,885 - $38,400
40 Added 1.77%
2,301 $2.04 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $55,090 - $69,087
76 Added 3.48%
2,261 $2.05 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $615,888 - $823,971
1,040 Added 90.83%
2,185 $1.7 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $21,007 - $24,765
40 Added 3.62%
1,145 $667,000
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $200,831 - $276,876
462 Added 71.85%
1,105 $593,000
Q2 2023

Aug 15, 2023

BUY
$350.74 - $468.98 $2,805 - $3,751
8 Added 1.26%
643 $301,000
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $6,833 - $8,026
22 Added 3.59%
635 $218,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $34,405 - $40,089
-107 Reduced 14.86%
613 $224,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $2,964 - $3,378
-10 Reduced 1.37%
720 $233,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $4,180 - $4,909
-15 Reduced 2.01%
730 $237,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $167,513 - $207,884
745 New
745 $206,000
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $264,529 - $327,411
-2,222 Closed
0 $0
Q1 2019

May 20, 2019

SELL
$111.31 - $131.02 $3,116 - $3,668
-28 Reduced 1.24%
2,222 $288,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $193,185 - $241,447
2,250 New
2,250 $241,000
Q1 2018

May 10, 2018

SELL
$74.21 - $87.6 $189,977 - $224,256
-2,560 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $197,299 - $218,982
2,560
2,560 $219,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.